These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 11379854)

  • 1. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
    Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
    Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
    Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
    Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
    Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions.
    Montenegro J; Saracho RM; Martínez IM; Muñoz RI; Ocharan JJ; Valladares E
    Perit Dial Int; 2006; 26(1):89-94. PubMed ID: 16538881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ionized sodium concentrations on ultrafiltration rate in peritoneal dialysis using lactate and lactate/bicarbonate solutions.
    La Milia V; Limardo M; Crepaldi M; Locatelli F
    Perit Dial Int; 2009; 29(2):158-62. PubMed ID: 19293352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.
    Simonsen O; Sterner G; Carlsson O; Wieslander A; Rippe B
    Perit Dial Int; 2006; 26(3):353-9. PubMed ID: 16722029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group.
    Tranaeus A
    Perit Dial Int; 2000; 20(5):516-23. PubMed ID: 11117242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution.
    García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V
    Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.
    Plum J; Razeghi P; Lordnejad RM; Perniok A; Fleisch M; Fusshöller A; Schneider M; Grabensee B
    Am J Kidney Dis; 2001 Oct; 38(4):867-75. PubMed ID: 11576893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidosis correction with a new 25 mmol/l bicarbonate/15 mmol/l lactate peritoneal dialysis solution.
    Carrasco AM; Rubio MA; Sanchez Tommero JA; Fernandez Girón F; Gonzalez Rico M; del Peso Gilsanz G; Fernandez Perpén A; Ramón RG; Bueno IF; Tranaeus A; Faict D; Hopwood A
    Perit Dial Int; 2001; 21(6):546-53. PubMed ID: 11783762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes.
    Plum J; Lordnejad MR; Grabensee B
    Kidney Int; 1998 Jul; 54(1):224-35. PubMed ID: 9648083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.